Cargando…

Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model

BACKGROUND: To use network pharmacology and gut microbiota sequencing to investigate the probable mechanism of Bining decoction (BN) in the treatment of gouty nephropathy (GN). METHODS: Firstly, the mechanism of therapeutic effects of BN on GN were collected by integrating network pharmacology. Seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huili, Tong, Ying, Fu, Tong, Lin, Danmei, Li, Hansheng, Xu, Li, Zhang, Senyue, Yin, Yanzhe, Gao, Yiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816844/
https://www.ncbi.nlm.nih.gov/pubmed/36618800
http://dx.doi.org/10.21037/atm-22-5523
_version_ 1784864630799073280
author Huang, Huili
Tong, Ying
Fu, Tong
Lin, Danmei
Li, Hansheng
Xu, Li
Zhang, Senyue
Yin, Yanzhe
Gao, Yiran
author_facet Huang, Huili
Tong, Ying
Fu, Tong
Lin, Danmei
Li, Hansheng
Xu, Li
Zhang, Senyue
Yin, Yanzhe
Gao, Yiran
author_sort Huang, Huili
collection PubMed
description BACKGROUND: To use network pharmacology and gut microbiota sequencing to investigate the probable mechanism of Bining decoction (BN) in the treatment of gouty nephropathy (GN). METHODS: Firstly, the mechanism of therapeutic effects of BN on GN were collected by integrating network pharmacology. Secondly, the treatment effects of BN against GN in 30 Institute of Cancer Research (ICR) mice were evaluated by performing biochemical tests [uric acid, blood urea nitrogen, and creatinine (UA, BUN, and Cr)] and evaluating the renal weight index. Finally, 16S rRNA sequencing was utilized for elucidating the therapeutical effect of BN in GN. RESULTS: The results of gut microbiota sequencing analysis showed the abundance of Faecalibaculum, Romboutsia, Bifidobacterium, Bacteroides, Odoribacter, Lachnospiraceae NK4A136 group, unclassified_f__Lachnospiraceae, Roseburia, norank_f__Lachnospiraceae, Lactobacillus, Dubosiella, norank_f__Muribaculaceae, and Turicibacter in the BN group had a significant changed between-group comparisons. Using a network pharmacology-related database, 413 active components of BN were identified, as well as 1,085 GN-associated targets. The 118 targets of disease targets and component targets were mapped, of which the top 10 genes were selected. The Kyoto Encyclopedia of Genes and Genomes (KEGG) results showed that 157 pathways were enriched, which was partially consistent with the metabolic pathways of gut microbiota sequencing analysis. CONCLUSIONS: Combining 16S rRNA gene sequencing and network pharmacology analysis, similar signaling pathways were followed: “Pathways in cancer” and “Adipocytokine signaling pathway”. The results reveal that BN increases the abundance of Turicibacter, regulates the expression of JAK2 in the JAK/STAT pathway, increases the beneficial bacteria Turicibacter associated with intestinal butyric acid, which could enhance the intestinal barrier, and exert anti-inflammatory effects.
format Online
Article
Text
id pubmed-9816844
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-98168442023-01-07 Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model Huang, Huili Tong, Ying Fu, Tong Lin, Danmei Li, Hansheng Xu, Li Zhang, Senyue Yin, Yanzhe Gao, Yiran Ann Transl Med Original Article BACKGROUND: To use network pharmacology and gut microbiota sequencing to investigate the probable mechanism of Bining decoction (BN) in the treatment of gouty nephropathy (GN). METHODS: Firstly, the mechanism of therapeutic effects of BN on GN were collected by integrating network pharmacology. Secondly, the treatment effects of BN against GN in 30 Institute of Cancer Research (ICR) mice were evaluated by performing biochemical tests [uric acid, blood urea nitrogen, and creatinine (UA, BUN, and Cr)] and evaluating the renal weight index. Finally, 16S rRNA sequencing was utilized for elucidating the therapeutical effect of BN in GN. RESULTS: The results of gut microbiota sequencing analysis showed the abundance of Faecalibaculum, Romboutsia, Bifidobacterium, Bacteroides, Odoribacter, Lachnospiraceae NK4A136 group, unclassified_f__Lachnospiraceae, Roseburia, norank_f__Lachnospiraceae, Lactobacillus, Dubosiella, norank_f__Muribaculaceae, and Turicibacter in the BN group had a significant changed between-group comparisons. Using a network pharmacology-related database, 413 active components of BN were identified, as well as 1,085 GN-associated targets. The 118 targets of disease targets and component targets were mapped, of which the top 10 genes were selected. The Kyoto Encyclopedia of Genes and Genomes (KEGG) results showed that 157 pathways were enriched, which was partially consistent with the metabolic pathways of gut microbiota sequencing analysis. CONCLUSIONS: Combining 16S rRNA gene sequencing and network pharmacology analysis, similar signaling pathways were followed: “Pathways in cancer” and “Adipocytokine signaling pathway”. The results reveal that BN increases the abundance of Turicibacter, regulates the expression of JAK2 in the JAK/STAT pathway, increases the beneficial bacteria Turicibacter associated with intestinal butyric acid, which could enhance the intestinal barrier, and exert anti-inflammatory effects. AME Publishing Company 2022-12 /pmc/articles/PMC9816844/ /pubmed/36618800 http://dx.doi.org/10.21037/atm-22-5523 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Huang, Huili
Tong, Ying
Fu, Tong
Lin, Danmei
Li, Hansheng
Xu, Li
Zhang, Senyue
Yin, Yanzhe
Gao, Yiran
Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
title Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
title_full Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
title_fullStr Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
title_full_unstemmed Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
title_short Effect of Bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
title_sort effect of bining decoction on gouty nephropathy: a network pharmacology analysis and preliminary validation of gut microbiota in a mouse model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816844/
https://www.ncbi.nlm.nih.gov/pubmed/36618800
http://dx.doi.org/10.21037/atm-22-5523
work_keys_str_mv AT huanghuili effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT tongying effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT futong effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT lindanmei effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT lihansheng effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT xuli effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT zhangsenyue effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT yinyanzhe effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel
AT gaoyiran effectofbiningdecoctionongoutynephropathyanetworkpharmacologyanalysisandpreliminaryvalidationofgutmicrobiotainamousemodel